STAT3 and intrahepatic cholangiocarcinoma: E-cadherin was decreased while vimentin and IL-10 were simultaneously increased in the experimental group, as demonstrated by immunohistochemistry, suggesting that M2-TAMs modulate malignant properties via IL-10/STAT3 in ICC cells and could block the effect of the signaling molecule-specific repressor.